Literature DB >> 25229463

With all the new treatment regimens, complete elimination of hepatitis C virus in Canada is a possibility! But when will Canadians have access these drugs?

Kevork M Peltekian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25229463      PMCID： PMC4210230          DOI： 10.1155/2014/140864

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  6 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  The Second Canadian Symposium on hepatitis C virus: a call to action.

Authors:  Jason Grebely; Marc Bilodeau; Jordan J Feld; Julie Bruneau; Benedikt Fischer; Jennifer F Raven; Eve Roberts; Norma Choucha; Rob P Myers; Selena M Sagan; Joyce A Wilson; Frank Bialystok; D Lorne Tyrrell; Michael Houghton; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

3.  Hepatitis C virus vaccines in the era of new direct-acting antivirals.

Authors:  Chao Shi; Alexander Ploss
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-02       Impact factor: 3.869

4.  A meta-analysis of the success rate of Helicobacter pylori therapy in Canada.

Authors:  Christopher Rodgers; Sander Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

Review 5.  Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.

Authors:  Alan Hoi Lun Yau; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

Review 6.  Burden of disease and cost of chronic hepatitis C infection in Canada.

Authors:  Robert P Myers; Mel Krajden; Marc Bilodeau; Kelly Kaita; Paul Marotta; Kevork Peltekian; Alnoor Ramji; Chris Estes; Homie Razavi; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05
  6 in total
  1 in total

1.  A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.

Authors:  Nasheed Moqueet; Cynthia Kanagaratham; M John Gill; Mark Hull; Sharon Walmsley; Danuta Radzioch; Sahar Saeed; Robert W Platt; Marina B Klein
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.